KEGG: sac:SACOL1630
STRING: 93062.SACOL1630
SACOL1630 is a full-length protein belonging to the UPF0365 protein family found in Staphylococcus aureus. The UPF designation (Uncharacterized Protein Family) indicates that its complete functional characterization remains ongoing. Based on homology with other UPF0365 proteins like NWMN_1476, it appears to be related to flotillin-like proteins (FloA) that participate in membrane organization and cellular processes . The complete amino acid sequence spans approximately 329 residues, similar to its homologs, and contains characteristic membrane-associated domains that suggest involvement in bacterial membrane organization .
While both SACOL1630 and NWMN_1476 belong to the UPF0365 protein family in S. aureus, they originate from different S. aureus strains and may exhibit subtle sequence variations. NWMN_1476 (from strain Newman) has been annotated as flotillin-like protein FloA with a UniProt ID of A6QHB6 . Comparative sequence analysis between these proteins typically reveals high conservation of functional domains while showing strain-specific variations in non-critical regions. When designing experiments targeting SACOL1630, researchers should account for these strain-specific differences by performing multiple sequence alignments to identify conserved regions for antibody development or functional studies.
E. coli expression systems are most commonly used for recombinant production of S. aureus proteins like SACOL1630, particularly when studying structural properties . For functional studies requiring proper protein folding and post-translational modifications, researchers should consider:
E. coli systems: Ideal for high yield but may require optimization of codon usage and solubility tags
Yeast expression systems: Better for proteins requiring eukaryotic-like post-translational modifications
Insect cell systems: Suitable for membrane-associated proteins requiring complex folding
The selection depends on research objectives - structural studies may prioritize quantity over native conformation, while functional assays require properly folded protein . Based on successful expression of the homologous NWMN_1476 protein, E. coli systems with N-terminal His-tags have demonstrated effectiveness for UPF0365 family proteins .
For SACOL1630 purification, a multi-step approach typically yields the best results:
Initial capture: Immobilized metal affinity chromatography (IMAC) using Ni-NTA resin for His-tagged protein
Intermediate purification: Ion exchange chromatography to separate based on charge differences
Polishing step: Size exclusion chromatography to remove aggregates and ensure monodispersity
This strategy has shown effectiveness with homologous proteins like NWMN_1476 . Researchers should monitor purity via SDS-PAGE at each step, aiming for >90% purity. For membrane-associated proteins like SACOL1630, adding low concentrations (0.05-0.1%) of mild detergents (DDM or CHAPS) throughout the purification process can improve yield and prevent aggregation. Final protein should be stored in Tris/PBS-based buffer with 6% trehalose at pH 8.0 to maintain stability .
Differentiating the functional roles requires sophisticated experimental approaches:
Sequential gene knockout studies: Create single, double, and complementation mutants of SACOL1630 and related proteins
Domain swapping experiments: Exchange functional domains between SACOL1630 and other flotillin-like proteins to identify specific activity regions
Interactome mapping: Use pull-down assays coupled with mass spectrometry to identify differential protein interaction partners
| Experimental Approach | Advantages | Limitations | Data Analysis Method |
|---|---|---|---|
| Gene knockout | Direct assessment of phenotype | Potential compensatory mechanisms | Comparative phenotypic analysis |
| Domain swapping | Identifies functional regions | Complex cloning required | Structure-function correlation |
| Interactome analysis | Comprehensive protein network view | Resource intensive | Network analysis software (Cytoscape) |
When interpreting results, researchers should account for potential functional redundancy among flotillin-like proteins that may mask phenotypic effects in single knockout studies. Cross-referencing with transcriptomic data during various growth phases can provide additional context for functional differentiation .
To characterize SACOL1630's membrane organization role, researchers should implement complementary techniques:
Super-resolution microscopy: Techniques like STORM or PALM with fluorescently-tagged SACOL1630 can visualize protein clustering and distribution patterns within bacterial membranes at nanoscale resolution
Membrane fractionation with proteomics: Isolate membrane microdomains using detergent resistance methods followed by mass spectrometry to identify co-localized proteins
FRET analysis: Measure protein-protein interactions within membrane domains using acceptor photobleaching FRET between SACOL1630 and candidate interaction partners
For quantitative analysis of membrane localization, researchers should employ dual-channel imaging with appropriate membrane markers and calculate co-localization coefficients (Pearson's or Mander's). Membrane microdomain isolation requires careful optimization of detergent concentrations and temperatures to preserve native protein interactions .
When facing contradictory data about SACOL1630 function, implement this systematic analysis framework:
Context dependency analysis: Systematically compare experimental conditions (growth media, growth phase, strain backgrounds) that might explain discrepancies
Method-specific artifact assessment: Evaluate whether different detection methods might introduce bias (e.g., tag interference with protein function)
Statistical robustness evaluation: Assess sample sizes, technical replicates, and statistical methods used in contradictory studies
Create a comparison table of contradictory findings that includes:
Experimental conditions
Methodological approaches
Statistical significance
Sample sizes
Controls used
Researchers should prioritize orthogonal validation - confirming findings using methodologically distinct approaches to overcome technique-specific limitations. For unresolved contradictions, consider designing experiments specifically to test competing hypotheses under standardized conditions .
For optimal storage and reconstitution of recombinant SACOL1630:
Store lyophilized protein at -20°C/-80°C
Avoid repeated freeze-thaw cycles
Consider aliquoting reconstituted protein with 50% glycerol for multiple use cases
Centrifuge lyophilized protein vial briefly before opening
Reconstitute to 0.1-1.0 mg/mL using deionized sterile water
Add glycerol to 5-50% final concentration for stability
Store working aliquots at 4°C for up to one week
The ideal storage buffer composition is Tris/PBS-based buffer with 6% trehalose at pH 8.0 . Activity assays should be performed immediately after reconstitution and after storage to assess stability over time. For membrane-associated proteins like SACOL1630, addition of mild detergents during reconstitution may help maintain native conformation and prevent aggregation .
To evaluate SACOL1630's role in virulence, implement a multi-level experimental design:
Adhesion assays: Compare wild-type and SACOL1630 knockout strains for adherence to host cell lines
Biofilm formation: Quantify biofilm formation using crystal violet staining and confocal microscopy
Immune evasion: Assess survival in neutrophil killing assays and complement resistance tests
Animal infection models: Use murine models of systemic infection and tissue-specific models
Competitive index assays: Co-infect with wild-type and mutant strains to directly compare fitness
Bacterial burden tracking: Monitor tissue colonization over time using bioluminescent imaging
| Assessment Parameter | Methodology | Readout | Statistical Analysis |
|---|---|---|---|
| Adhesion capacity | Cell culture binding assay | % adherent bacteria | t-test or ANOVA |
| Biofilm formation | Crystal violet staining | Absorbance at 595nm | t-test with multiple timepoints |
| Virulence in vivo | Survival curves | Kaplan-Meier plot | Log-rank test |
| Tissue burden | CFU enumeration | Log10 CFU/g tissue | Mann-Whitney U test |
Include complementation controls to confirm phenotypes are specifically due to SACOL1630 loss. Additionally, gene expression analysis during infection provides context for when SACOL1630 is actively transcribed during pathogenesis .
For comprehensive identification of SACOL1630 interaction partners, employ these complementary proteomic approaches:
Co-immunoprecipitation with LC-MS/MS: Use anti-SACOL1630 antibodies or tagged protein versions to pull down protein complexes, followed by mass spectrometry identification
Proximity-dependent biotin labeling (BioID or APEX): Fuse SACOL1630 to a biotin ligase to label proximal proteins in living bacteria
Chemical cross-linking mass spectrometry (XL-MS): Use membrane-permeable crosslinkers to capture transient interactions before MS analysis
For effective implementation, consider:
Expression levels: Maintain near-native expression to avoid artificial interactions
Negative controls: Include non-specific IgG pulldowns or unrelated bacterial proteins fused to the same tags
Validation: Confirm key interactions using reciprocal pulldowns and co-localization studies
Data analysis should include:
Enrichment calculation against controls
Filtering based on spectral counts
Network analysis of identified interactions
The 2D-DIGE gel electrophoresis approach can be used to identify differentially expressed proteins in SACOL1630 knockout strains compared to wild-type, providing indirect evidence of functional pathways involving this protein .
To quantitatively assess SACOL1630's impact on membrane domain formation:
Fluorescence recovery after photobleaching (FRAP):
Tag membrane proteins with fluorescent markers
Measure diffusion rates in wild-type vs. SACOL1630 knockout strains
Calculate diffusion coefficients and mobile fractions
Atomic force microscopy (AFM):
Prepare membrane patches from wild-type and mutant bacteria
Measure nanomechanical properties of membrane domains
Quantify domain size, height, and stiffness
Detergent resistance membrane (DRM) isolation:
Isolate membrane fractions using density gradient centrifugation
Compare protein and lipid profiles between fractions
Quantify changes in domain-associated protein distribution
| Parameter | Wild-type measurement | ΔSACOL1630 measurement | Analysis method |
|---|---|---|---|
| Diffusion coefficient | D = X μm²/s | D = Y μm²/s | Non-linear regression of FRAP recovery |
| Domain size | Z nm | W nm | Particle analysis of AFM images |
| Protein distribution in DRMs | % in each fraction | % in each fraction | Densitometry of Western blots |
Statistical analysis should include multiple biological replicates (n≥3) and appropriate tests for significance. Consider complementary visualization using transmission electron microscopy with immunogold labeling to correlate quantitative measures with structural observations .
When interpreting phenotypic changes in SACOL1630 knockout strains, researchers should be aware of these common pitfalls:
Functional redundancy: Related proteins may compensate for SACOL1630 loss, masking phenotypes. Solution: Create multiple knockout strains of related proteins and assess combinatorial effects.
Polar effects on adjacent genes: Knockout constructs may disrupt expression of neighboring genes. Solution: Use clean deletion methods and complement with SACOL1630 expressed from a neutral site.
Secondary mutations: Adaptation to SACOL1630 loss may select for compensatory mutations. Solution: Create multiple independent knockout strains and sequence genomes to identify consistent phenotypes.
Growth rate confounding: Different growth rates between wild-type and mutant can confound phenotypic assays. Solution: Normalize data to growth parameters or use conditional expression systems.
Proper controls should include:
Wild-type parental strain
Complemented mutant strain
Empty vector control for complementation
Related protein knockouts for comparison
When analyzing growth curves and survival rates, consider both the growth rate (slope) and maximum density (plateau) as distinct parameters that may be differentially affected .
For robust analysis of SACOL1630 post-translational modifications (PTMs) by mass spectrometry:
Sample preparation optimization:
Use multiple proteases (not just trypsin) to ensure complete sequence coverage
Enrich for specific modifications using appropriate techniques (TiO2 for phosphopeptides, lectin chromatography for glycopeptides)
Data acquisition strategy:
Implement data-dependent acquisition (DDA) with inclusion lists for predicted modified peptides
Consider parallel reaction monitoring (PRM) for targeted analysis of suspected modification sites
Search parameters:
Set appropriate mass tolerances based on instrument capabilities
Include common PTMs as variable modifications (phosphorylation, acetylation, methylation)
Use decoy database searches to control false discovery rates
Validation criteria:
Require detection of diagnostic fragment ions that localize modifications to specific residues
Implement confidence scoring that accounts for spectral quality
Validate biological significance through site-directed mutagenesis
When reporting PTM data, include:
Modified sequence with modification sites clearly indicated
Spectra showing diagnostic ions
Quantitative data on modification stoichiometry
Biological replicates demonstrating reproducibility
Cross-reference findings with known modification patterns in homologous proteins like NWMN_1476 to identify conserved regulatory mechanisms .
The potential contribution of SACOL1630 to antimicrobial resistance requires investigation through these approaches:
Susceptibility profiling: Compare minimum inhibitory concentrations (MICs) of multiple antibiotic classes between wild-type and SACOL1630 mutant strains
Resistance mechanism assessment:
Measure membrane permeability using fluorescent dyes
Quantify efflux pump activity with substrate accumulation assays
Assess changes in cell wall thickness via electron microscopy
Stress response analysis:
Monitor SACOL1630 expression during antibiotic exposure
Determine if SACOL1630 co-localizes with resistance determinants during stress
| Antibiotic Class | Wild-type MIC | ΔSACOL1630 MIC | Fold Change | Proposed Mechanism |
|---|---|---|---|---|
| β-lactams | X μg/ml | Y μg/ml | Z-fold | Changes in membrane organization |
| Glycopeptides | X μg/ml | Y μg/ml | Z-fold | Altered cell wall synthesis |
| Macrolides | X μg/ml | Y μg/ml | Z-fold | Effect on efflux systems |
As a membrane organization protein related to flotillins, SACOL1630 may affect the distribution and function of membrane proteins involved in drug efflux or uptake. Researchers should also investigate potential roles in biofilm-associated resistance, as membrane microdomains often contribute to biofilm formation processes .
Emerging techniques for SACOL1630 structure-function analysis include:
AlphaFold2 and structure prediction:
Generate computational models of SACOL1630 structure
Identify putative functional domains and interaction surfaces
Validate predictions through site-directed mutagenesis
Single-molecule techniques:
Single-molecule FRET to measure conformational changes
Optical tweezers to assess protein-protein interaction forces
Super-resolution microscopy for membrane organization visualization
Integrative structural biology approaches:
Combine low-resolution techniques (SAXS, cryo-EM) with computational modeling
Validate domain interfaces through crosslinking mass spectrometry
Assess dynamics through hydrogen-deuterium exchange MS
For membrane proteins like SACOL1630, native mass spectrometry in nanodiscs represents a particularly promising approach for studying the protein in a membrane-like environment. These techniques can overcome the traditional challenges of membrane protein structural biology and provide insights into how SACOL1630 functions within the bacterial membrane context .
To comprehensively characterize SACOL1630 expression patterns:
Growth phase analysis:
Measure transcript levels by qRT-PCR across growth curve
Quantify protein abundance using targeted proteomics
Correlate expression with physiological transitions
Stress response profiling:
Expose cultures to relevant stresses (antibiotics, oxidative stress, nutrient limitation)
Monitor expression changes using reporter constructs
Compare with known stress response markers
Host interaction dynamics:
Assess expression during host cell infection models
Track protein localization changes during phagocytosis
Determine if host factors modulate expression
| Growth Phase/Condition | Transcript Level (Fold-Change) | Protein Level (Fold-Change) | Membrane Localization |
|---|---|---|---|
| Early exponential | Baseline | Baseline | Diffuse distribution |
| Late exponential | X-fold | Y-fold | Domain formation |
| Stationary | X-fold | Y-fold | Concentrated domains |
| Antibiotic stress | X-fold | Y-fold | Altered pattern |
Researchers should implement time-course experiments rather than single time-point measurements to capture the dynamics of expression changes. Transcriptomic data should be validated at the protein level, as post-transcriptional regulation can significantly impact actual protein abundance, particularly for membrane proteins .